ZnT2 facilitates zinc vesicular sequestration

Stable Identifier
R-HSA-435375
Type
Reaction [transition]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The human gene SLC30A2 encodes zinc transporter ZnT2. Its function was first inferred from experiments using rat Znt2 (Palmiter RD et al, 1996). In 2019, Golan et al. showed in human cells that SLC30A2 uses antiport of two protons to achieve electroneutral zinc transport.
Literature References
PubMed ID Title Journal Year
30893306 ZnT2 is an electroneutral proton-coupled vesicular antiporter displaying an apparent stoichiometry of two protons per zinc ion

Golan, Y, Alhadeff, R, Warshel, A, Assaraf, YG

PLoS Comput Biol 2019
8617223 ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration

Palmiter, RD, Cole, TB, Findley, SD

EMBO J 1996
Participants
Participates
Catalyst Activity

zinc ion transmembrane transporter activity of SLC30A2 [endosome membrane]

Inferred From
Cross References
RHEA
Authored
Reviewed
Created
Cite Us!